PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

In addition, doctors want to make sure that the person is up-to-date with their age-appropriate screenings, which include ...

Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...

Robert F. Kennedy Jr. and I rarely see eye to eye, but I’ll grudgingly admit he’s not entirely wrong about food dyes, though ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...

Ascentage Pharma Group International’s AAPG share price has surged by 7.56%, which has investors questioning if this is right ...

Atea Pharmaceuticals (AVIR) announced that the full results from the Phase 2 clinical study of Atea’s regimen of bemnifosbuvir, a nucleotide ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Former President Barack Obama has kept busy since he left office. From impromptu family vacations to court-mandated jury duty, the 63-year-old has led a pretty ordinary life in the years following ...

Enanta Pharmaceuticals, Inc.’s ENTA share price has surged by 5.48%, which has investors questioning if this is right time to sell.

“We demonstrated that gut metabolites impact the brain, and the brain, in turn, affects behavior,” study author Lisa Aziz-Zadeh said in a press release. “Essentially, the brain acts as the ...

The ongoing trade war between the US and China has significant implications for the global economy The United States and China are embroiled in a heated trade dispute, with the US imposing ...